A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease
Clinical trial NCT06978920 · RECRUITING
Trial details
- NCT number
- NCT06978920
- Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-06
- Primary completion
- 2026-07-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.